Team:Yale/Project/MAGE
From 2011.igem.org
(Difference between revisions)
Line 6: | Line 6: | ||
Multiplex automated genome engineering (MAGE) allows for large-scale programming and evolution of cells. Mediated by λ-Red ssDNA-binding protein β, oligos are incorporated into the lagging strand of the replication fork during DNA replication, creating a new allele that will spread through the population as the bacteria divide. The efficiency of oligo incorporation depends on several factors, but the frequency of the allele can be increased by performing multiple rounds of MAGE on the same cell culture. MAGE facilitates rapid and continuous generation of a diverse set of genetic changes (mismatches, insertions, deletions). This multiplex approach embraces engineering in the context of evolution by expediting the design and evolution of organisms with new and improved properties. | Multiplex automated genome engineering (MAGE) allows for large-scale programming and evolution of cells. Mediated by λ-Red ssDNA-binding protein β, oligos are incorporated into the lagging strand of the replication fork during DNA replication, creating a new allele that will spread through the population as the bacteria divide. The efficiency of oligo incorporation depends on several factors, but the frequency of the allele can be increased by performing multiple rounds of MAGE on the same cell culture. MAGE facilitates rapid and continuous generation of a diverse set of genetic changes (mismatches, insertions, deletions). This multiplex approach embraces engineering in the context of evolution by expediting the design and evolution of organisms with new and improved properties. | ||
<br /><img src="https://static.igem.org/mediawiki/2011/f/f3/Mage1.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | <br /><img src="https://static.igem.org/mediawiki/2011/f/f3/Mage1.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | ||
- | Figure adapted from Wang et al., 2009. Each cell contains a different set of mutations, producing a heterogeneous population of rich diversity (denoted by distinct chromosomes in different cells). Degenerate oligo pools that target specific genomic positions enable the generation of a diverse set of sequences at each chromosomal location. (Wang et al, 2009) <br /><img src="https://static.igem.org/mediawiki/2011/3/3d/Mage2.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> This figure is from Wang et al., 2009 | + | Figure adapted from Wang et al., 2009. Each cell contains a different set of mutations, producing a heterogeneous population of rich diversity (denoted by distinct chromosomes in different cells). Degenerate oligo pools that target specific genomic positions enable the generation of a diverse set of sequences at each chromosomal location. (Wang et al, 2009) <br /><img src="https://static.igem.org/mediawiki/2011/3/3d/Mage2.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> This figure is from Wang et al., 2009. MAGE is capable of producing mismatches, insertions or deletions.<br /><br /><img src="https://static.igem.org/mediawiki/2011/1/1d/Mage3.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> |
This graphic, from Farren Isaacs, describes how to design oligos for MAGE. Our oligos were approximately 90 bases long with the first 5’ base phosphorothioated (increases recombination efficiency). Since we integrated the RiAFP into the genome in replichore 1 (sites 78110 and 1415740; determined at ecocyc.org), we designed oligos to target the appropriate strand. Mismatches, insertions, and deletions were centered on the oligo to increase recombination efficiency.<br /><img src="https://static.igem.org/mediawiki/2011/1/1f/Mage4.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /><br />This figure (Wang, 2009) describes the efficiency of incorporation for different types of sequence modifications. <br /><br />In order to perform MAGE, we needed to first integrate RiAFP into the genome of the EcNR2 strain. The RiAFP gene was linked to kanamycin by crossover PCR. dsDNA recombination efficiency data from Conjugative Assembly Genome Engineering (Isaacs, et al 2011). For further details, please see protocols section. <br /><img src="https://static.igem.org/mediawiki/2011/7/75/Mage5.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | This graphic, from Farren Isaacs, describes how to design oligos for MAGE. Our oligos were approximately 90 bases long with the first 5’ base phosphorothioated (increases recombination efficiency). Since we integrated the RiAFP into the genome in replichore 1 (sites 78110 and 1415740; determined at ecocyc.org), we designed oligos to target the appropriate strand. Mismatches, insertions, and deletions were centered on the oligo to increase recombination efficiency.<br /><img src="https://static.igem.org/mediawiki/2011/1/1f/Mage4.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /><br />This figure (Wang, 2009) describes the efficiency of incorporation for different types of sequence modifications. <br /><br />In order to perform MAGE, we needed to first integrate RiAFP into the genome of the EcNR2 strain. The RiAFP gene was linked to kanamycin by crossover PCR. dsDNA recombination efficiency data from Conjugative Assembly Genome Engineering (Isaacs, et al 2011). For further details, please see protocols section. <br /><img src="https://static.igem.org/mediawiki/2011/7/75/Mage5.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | ||
Gel confirming success of PCR reactions for eventual crossover PCR. 1: 100 bp ladder, 2: 1kb ladder, 3: 1kb ladder, 4: GR7 - i (PCR reaction for RiGFP, 78 integration site, and Kan crossover site), 5: replicate of above, 6: replicate of above, 7: 141Kan - i (PCR reaction for Kanamycin, 141 integration site), 8: replicate of above, 9: replicate of above, 10: GR14 - i (PCR reaction for RiGFP, 141 integration site, and Kan crossover site), 11: replicate of above, 12: replicate of above, 13: 78Kan - i (PCR reaction for Kanamycin, 78 integration site), 14: replicate of above, 15: replicate of above <br /><img src="https://static.igem.org/mediawiki/2011/c/c8/Mage6.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | Gel confirming success of PCR reactions for eventual crossover PCR. 1: 100 bp ladder, 2: 1kb ladder, 3: 1kb ladder, 4: GR7 - i (PCR reaction for RiGFP, 78 integration site, and Kan crossover site), 5: replicate of above, 6: replicate of above, 7: 141Kan - i (PCR reaction for Kanamycin, 141 integration site), 8: replicate of above, 9: replicate of above, 10: GR14 - i (PCR reaction for RiGFP, 141 integration site, and Kan crossover site), 11: replicate of above, 12: replicate of above, 13: 78Kan - i (PCR reaction for Kanamycin, 78 integration site), 14: replicate of above, 15: replicate of above <br /><img src="https://static.igem.org/mediawiki/2011/c/c8/Mage6.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> |
Revision as of 03:13, 29 September 2011